Clinical TrialID 17

Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue

NCT01043913

Signs and Symptoms|Neoplasms|Neoplasms by Site|Fatigue|Breast Neoplasms|Breast Diseases

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
17
Evidence Id
17
Core Evidence Id
17
Source Clinical Trial Id
12
Herb2 Clinical Trial Id
HBCT000012
Nct Id
NCT01043913
Title
Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue
Status
Completed
Phase
Phase 2
Study Result
No
Study Condition
Signs and Symptoms|Neoplasms|Neoplasms by Site|Fatigue|Breast Neoplasms|Breast Diseases
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Guarana extract
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Triple
Intervention Purpose
Treatment
Gender
Female
Age
Adult, Older_Adult
Enrollment
60
Outcome Measure
Fatigue improvement between the baseline to D21 or from D21 to D42 measured by Chalder Fatigue Scale, FACT-F and FACT-ES questionnaires, 42 days
Sponsor Collaborator
Faculdade de Medicina do ABC
Funded By
OTHER
Location
Faculdade de Medicina do ABC, Santo Andre, SP, 09060650, Brazil
Other Id
mairapaschoin
Start Date
2008-02
Primary Completion Date
2009-09
Completion Date
2009-12
First Posted
2010-01-07
Results First Posted
Last Update Posted
2010-01-07
Study Document
Study Url
https://clinicaltrials.gov/study/NCT01043913
Title Cn
Title En
Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue
Bilingual Status
semi_complete